In Table 1 , the 'group treated with the current ARB' BMI score should read 26.6±2.2, and not 26.6±1.9, as reported. Also, the BMI max-min scores for both groups should read 33.0-23.6 (telmisartan group) and 30.6-24.5 (ARB group), not 25.0-31.3 and 25.0-30.6, as reported. In Table 2 , the baseline HbA1c result for the current ARB group should read 5.66±0.52, and not 5.56±0.52, and the 6 month LDL cholesterol result for the telmisartan group should read 109.6±30.0, not 109.6±30.3, as reported. In Figure 1A the P value should be P<0.05, not P=0.05. In Figures 1 and 2 , the x axis values were slightly incorrect; the correct figures are shown below. The authors regret the errors, and thank Springer Healthcare for publishing the correction. ARB=angiotensin II receptor blocker; BMI=body mass index; HbA1c=hemoglobin A1c.
